Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.
Melendez-Torres GJ, Auguste P, Armoiry X, Maheswaran H, Court R, Madan J, Kan A, Lin S, Counsell C, Patterson J, Rodrigues J, Ciccarelli O, Fraser H, Clarke A. Melendez-Torres GJ, et al. Among authors: kan a. Health Technol Assess. 2017 Sep;21(52):1-352. doi: 10.3310/hta21520. Health Technol Assess. 2017. PMID: 28914229 Free PMC article. Review.
Short- and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome: a systematic review of randomised controlled trials and network meta-analysis.
Armoiry X, Kan A, Melendez-Torres GJ, Court R, Sutcliffe P, Auguste P, Madan J, Counsell C, Clarke A. Armoiry X, et al. Among authors: kan a. J Neurol. 2018 May;265(5):999-1009. doi: 10.1007/s00415-018-8752-8. Epub 2018 Jan 22. J Neurol. 2018. PMID: 29356977 Free PMC article. Review.
Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages.
Melendez-Torres GJ, Armoiry X, Court R, Patterson J, Kan A, Auguste P, Madan J, Counsell C, Ciccarelli O, Clarke A. Melendez-Torres GJ, et al. Among authors: kan a. BMC Neurol. 2018 Oct 3;18(1):162. doi: 10.1186/s12883-018-1162-9. BMC Neurol. 2018. PMID: 30285675 Free PMC article. Review.
Understanding paralogous epilepsy-associated GABAA receptor variants: Clinical implications, mechanisms, and potential pitfalls.
Kan ASH, Kusay AS, Mohammadi NA, Lin SXN, Liao VWY, Lesca G, Souci S, Milh M, Christophersen P, Chebib M, Møller RS, Absalom NL, Jensen AA, Ahring PK. Kan ASH, et al. Proc Natl Acad Sci U S A. 2024 Dec 10;121(50):e2413011121. doi: 10.1073/pnas.2413011121. Epub 2024 Dec 6. Proc Natl Acad Sci U S A. 2024. PMID: 39642202 Free PMC article.
472 results